Keyphrases
Agranulocytosis
15%
Antibodies to Infliximab
17%
Anticoagulation
28%
Clinical Characteristics
17%
Clinical Outcomes
23%
Clinically Significant
16%
Community Setting
15%
Confidence Interval
22%
CYP2C9
28%
Database Testing
15%
Deferiprone
39%
Dose Requirement
22%
Drug Withdrawal
15%
During Pregnancy
53%
Excessive Anticoagulation
15%
Gestational Exposure
23%
Hospitalized Patients
18%
Ifosfamide
15%
Individual Sensitivity
16%
Inflammatory Bowel Disease
20%
Infliximab
26%
International Normalized Ratio
33%
Israel
27%
Low-dose Methotrexate
15%
Multivariate Analysis
16%
Multivitamins
15%
Nephrotoxicity
15%
Non-associated
16%
Nurture
15%
Pharmacogenetics
23%
Pharmacokinetics
33%
Pregnancy Outcome
31%
Pregnant Women
29%
Prospective Controlled Study
23%
Pyroglutamic Acid
15%
QT Prolongation
23%
Risk Factors
35%
Rosiglitazone
15%
Tertiary Care Hospital
17%
Thalassemia
17%
Type 2 Diabetic Patients
15%
Varicella Zoster Immune Globulin
15%
Vitamin K
37%
Vitamin K1
23%
VKORC1
25%
Voriconazole
15%
Warfarin
84%
Warfarin Dose
49%
Warfarin Pharmacogenetics
16%
β-Thalassemia (β-thal)
17%
Pharmacology, Toxicology and Pharmaceutical Science
Adalimumab
9%
Agranulocytosis
15%
Allergic Rhinitis
15%
Anticoagulant Agent
12%
Antihistaminic Agent
12%
Ascorbic Acid
9%
Breast Cancer
15%
Chemotherapy
9%
Cohort Study
27%
Congenital Malformation
25%
Crohn's Disease
9%
CYP2C9
14%
Deferiprone
39%
Diabetes Mellitus
13%
Diabetic Nephropathy
15%
Disease
20%
Drug Utilization
9%
Drug-Drug Interaction
11%
Electronic Prescribing
15%
Elimination
15%
Free Radical
13%
Herpes Zoster Immunoglobulin
15%
Infection
15%
Inflammatory Bowel Disease
19%
Infliximab
25%
Iron Chelating Agent
11%
Malignant Neoplasm
10%
Metabolic Acidosis
15%
Methotrexate
15%
Multivitamin
15%
Non Insulin Dependent Diabetes Mellitus
15%
Pharmacodynamics
9%
Pharmacogenetics
21%
Pharmacokinetics
40%
Pharmacotherapy
15%
Phytomenadione
23%
Premature Labor
10%
Prevalence
11%
Prospective Study
33%
Prothrombin
9%
Pyroglutamic Acid
15%
Quinolone Derivative
15%
Retrospective Study
18%
Rosiglitazone
15%
Thalassemia
15%
Trough Level
9%
Tumor Necrosis Factor
16%
Vitamin K Group
34%
Voriconazole
15%
Warfarin
100%
Medicine and Dentistry
Acidosis
7%
Allergic Rhinitis
15%
Anion Gap
7%
Anticoagulation
7%
Beta Thalassemia
7%
Breast Cancer
15%
Breast Tumor
7%
Caffeine Citrate
7%
Clinical Decision Support System
15%
Congenital Malformation
16%
Diabetes Mellitus
13%
Diabetic Nephropathy
15%
Disease
13%
Drug Prescription
7%
Drug Therapy
20%
Electronic Prescribing
13%
Esmolol
7%
Fentanyl
7%
Fetal Alcohol Syndrome
11%
First Trimester Pregnancy
10%
Free Radical
13%
Gonad Function
7%
Health Care Cost
14%
Histamine Antagonist
10%
Hypomagnesemia
7%
Ifosfamide
15%
Intelligence Quotient
7%
Internal Medicine
11%
Isopentenyl Diphosphate
7%
Malignant Neoplasm
11%
Metabolic Acidosis
7%
Microalbuminuria
8%
Motherisk
7%
Multivitamin
7%
Nephrotoxicity
15%
Nerve Cell Differentiation
7%
Pediatrics
9%
Phylloquinone
7%
Propofol
7%
Prospective Study
26%
Psychoactive Drug
7%
QT Prolongation
7%
Retrospective Study
9%
Single Drug Dose
7%
Systemic Scleroderma
7%
T Cell
9%
Tertiary Care
15%
Thalassemia
15%
Voriconazole
15%
Zoledronic Acid
10%